Qianying Liu Selected Research

Qianying Liu Research Topics

Disease

7	Neoplasms (Cancer) 02/2024 - 07/2017
4	Infections 12/2023 - 01/2017
4	Pain (Aches) 01/2019 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2017
3	Multiple Myeloma 01/2020 - 01/2019
3	Hyperalgesia 01/2019 - 01/2018
3	Body Weight (Weight, Body) 01/2018 - 01/2017
2	Carcinogenesis 02/2024 - 05/2019
2	Bacterial Infections (Bacterial Infection) 12/2023 - 09/2019
2	Inflammation (Inflammations) 12/2023 - 01/2018
2	Bone Neoplasms (Bone Cancer) 01/2019 - 01/2018
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2018 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2018
1	Non-alcoholic Fatty Liver Disease 02/2024
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023
1	Genetic Risk Score 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2023
1	Hypocalcemia 11/2023
1	Hypokalemia 11/2023
1	Anemia 11/2023
1	Acidosis 11/2023
1	Cardiac Arrhythmias (Arrythmia) 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Heart Failure 11/2023
1	Kidney Diseases (Kidney Disease) 11/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Pulmonary Tuberculosis 01/2023
1	Tuberculosis (Tuberculoses) 01/2023
1	COVID-19 01/2022
1	Dementia (Dementias) 01/2021
1	Hypotension (Low Blood Pressure) 03/2020
1	Lymphoma (Lymphomas) 01/2020
1	Mastitis 10/2019
1	Hypersensitivity (Allergy) 01/2019
1	Chronic Pain 01/2019
1	Stroke (Strokes) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019

Drug/Important Bio-Agent (IBA)

4	plerixafor FDA Link 01/2020 - 01/2019
3	ArsenicIBA 02/2024 - 11/2023
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 01/2019
2	Cyclin-Dependent Kinase 4IBA 01/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2022
2	Estrogen ReceptorsIBA 01/2023 - 01/2022
2	Neutralizing AntibodiesIBA 01/2022 - 01/2019
2	marbofloxacinIBA 01/2017 - 01/2017
1	ORALIT (ORS)IBA 02/2024
1	Insulin (Novolin)FDA Link 02/2024
1	Insulin-Like PeptidesIBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2024
1	Peptides (Polypeptides)IBA 12/2023
1	EnzymesIBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	7-hydroxycoumarin (umbelliferone)IBA 12/2023
1	Parathyroid Hormone (Parathormone)IBA 11/2023
1	NitrogenIBA 11/2023
1	CreatinineIBA 11/2023
1	Urea (Carbamide)FDA LinkGeneric 11/2023
1	MicroRNAs (MicroRNA)IBA 11/2023
1	CarcinogensIBA 11/2023
1	Bispecific AntibodiesIBA 10/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2022
1	EpitopesIBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	AntibodiesIBA 01/2022
1	palbociclibIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Aromatase InhibitorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	pomalidomideIBA 11/2019
1	isatuximabIBA 11/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019
1	Lipid NanoparticlesIBA 10/2019
1	HydrogelsIBA 10/2019
1	tilmicosinIBA 10/2019
1	AlginatesIBA 10/2019
1	ChitosanIBA 10/2019
1	polyethylene glycol polyethyleneimine nanogelIBA 10/2019
1	Anti-Infective Agents (Microbicides)IBA 09/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2019
1	SB 225002IBA 01/2019
1	ChemokinesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	AcidsIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	CaspasesIBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2023 - 12/2017
2	Hematopoietic Stem Cell Mobilization 01/2020 - 01/2020
2	Transplantation 01/2020 - 01/2019
1	Retreatment 01/2023
1	Spinal Anesthesia 03/2020
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Blood Component Removal (Apheresis) 01/2019
1	Radiofrequency Ablation 01/2019